MMRF Molecular Profiling Protocol

Status unconfirmed

Conditions studied: Multiple Myeloma, Plasma Malignancy

In brief

This protocol is now being used as screening for the MyDRUG study

Key facts

Study ID

NCT02884102

Run by

Multiple Myeloma Research Foundation

People needed

1000

Starts

2015-06-01

Expected to finish

2026-06-01

Last updated by the study team

2025-05-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have a diagnosis of multiple myeloma or related malignancy
• Patients are undergoing standard of care bone marrow aspirates
• Patients (male or female) from any race or ethnicity must be at least 18 years of age at the time of registration.
• Procedure-specific signed informed consent form prior to initiation of any study-related procedures.

You may not qualify if…

• It is the enrolling study physician's discretion to decide if a patient is not fit enough to undergo a bone marrow aspirate.
• Patients who are incarcerated are not eligible to participate.
• Women who are pregnant
• Patients who have had another malignancy within the last five (5) years (except for basal or squamous cell carcinoma, or in situ cancer of the cervix) where there is a possibility to contaminate the bone marrow aspirate.

Where it is running

• Mayo Clinic - Scottsdale — Scottsdale, Arizona, United States
• City of Hope — Duarte, California, United States
• UCSF Medical Center — San Francisco, California, United States
• Mayo Clinic - Jacksonville — Jacksonville, Florida, United States
• Emory University — Atlanta, Georgia, United States
• University of Chicago — Chicago, Illinois, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States
• University of Michigan — Ann Arbor, Michigan, United States
• Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
• Mayo Clinic - Rochester — Rochester, Minnesota, United States
• Washington University — St Louis, Missouri, United States
• Hackensack University Medical Center — Hackensack, New Jersey, United States
• Mount Sinai Medical Center — New York, New York, United States
• Levine Cancer Institute — Charlotte, North Carolina, United States
• Ohio State University — Columbus, Ohio, United States
• Sarah Cannon Research Institute — Nashville, Tennessee, United States
• Baylor Research Institute — Dallas, Texas, United States
• Virginia Cancer Specialists — Fairfax, Virginia, United States
• Princess Margaret Cancer Centre — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.